No..although an approval of Vyvanse, which in highly unlikely, is probably already in the pps...which would make it a short candidate...however shorting is too risky for my blood with an individual stock...I've been short the general indexes (using ETF's) for almost 2 years now..been very painful..but when the collapse comes we will see lows of 08-09 or even lower...just around the corner now...Elite likely will be spared...So I continue to hold
Market Data 
Markets 
AI
